Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results71% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (4)
P 2 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed5
Terminated2
Not Yet Recruiting2
Recruiting1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (10)

Research Network

Activity Timeline